Fingerpaint Group Taps Area 23 Executive as Marketing GM

  • Latifa Alladina joins Fingerpaint Marketing as General Manager, bringing 25 years of experience in client-side brand leadership and agency roles.
  • Alladina previously served as EVP and Executive Director at Area 23 for nearly 11 years.
  • Fingerpaint Group reported 21% revenue growth in 2025, its 15th consecutive year on MM+M's top 100 agencies list.
  • Alladina's expertise spans rare disease, neurology, and immunology therapeutic categories.

Fingerpaint Group's appointment of Latifa Alladina underscores the growing emphasis on hybrid leadership that combines deep scientific knowledge with commercial strategy. The move comes as healthcare marketing agencies face pressure to deliver data-driven solutions while maintaining creative differentiation. With 95% of the top 20 global pharmaceutical companies as clients, Fingerpaint's ability to attract and retain top talent will be critical in maintaining its position as a top 25 healthcare agency.

Strategic Alignment
How Alladina's scientific and commercial background will integrate with Fingerpaint's human-led, AI-enabled approach.
Growth Trajectory
Whether Fingerpaint can sustain its 21% revenue growth amid increasing competition in healthcare marketing.
Client Retention
The pace at which Fingerpaint can leverage Alladina's experience to strengthen partnerships with top 20 global pharmaceutical clients.